Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Camp4 Therapeutics Corp: Adopted amended and restated bylaws to establish procedures for stockholder proposals and director nominations, modify indemnification provisions, and conform to the amended charter (effective 2024-10-15).
- Change
- bylaw amendment
- Effective
- 2024-10-15
Exact text from the filing
On October 15, 2024, in connection with the consummation of the IPO, the amended and restated bylaws of the Company (the “Amended and Restated Bylaws”), previously approved by the Company’s board of directors and stockholders, became effective.
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Camp4 Therapeutics Corp: Filed fifth amended and restated certificate of incorporation to increase authorized common stock, eliminate references to existing preferred, authorize undesignated preferred stock, and eliminate stockholder action by written consent (effective 2024-10-15).
- Change
- charter amendment
- Effective
- 2024-10-15
Exact text from the filing
On October 15, 2024, in connection with the consummation of the initial public offering (the “IPO”) of shares of common stock, par value $0.0001 per share (“Common Stock”), of CAMP4 Therapeutics Corporation (the “Company”), the Company filed a fifth amended and restated certificate of incorporation (the “Restated Certificate”) with the Secretary of State of the State of Delaware, which became effective upon filing.
View on SEC.gov